Inactive Instrument

News Neuralstem, Inc. Nasdaq

Equities

US64127R3021

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 16	Sector Update: Health Care Stocks Edge Up Tuesday Afternoon	MT
Apr. 16	Palisade Bio Shows Bioactivation of PALI-2108 in Study; Shares Rise	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 in Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients Stool	Apr. 17	AQ
Sector Update: Health Care Stocks Edge Up Tuesday Afternoon	Apr. 16	MT
Palisade Bio Shows Bioactivation of PALI-2108 in Study; Shares Rise	Apr. 16	MT
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool	Apr. 16	AQ
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients? Stool	Apr. 16	CI
Palisade Bio to Participate in the Virtual Investor Lunch Break Event	Apr. 11	AQ
Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™	Apr. 10	AQ
Palisade Bio Announces 1-for-15 Reverse Stock Split	Apr. 03	AQ
North American Morning Briefing : Stocks Seen -2-	Apr. 02	DJ
Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate Update	Mar. 27	AQ
Palisade Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Palisade Bio, Inc. Announces Resignation of Mary Ann Gray as Member of the Board	Mar. 06	CI
Palisade Bio to Present at Digestive Disease Week (DDW) 2024	Feb. 15	AQ
Palisade Bio Names Donald Williams as Chairman	Feb. 13	MT
Palisade Bio Provides Corporate Update and Reiterates Guidance	Feb. 13	AQ
Correction Notice of Palisade Bio’s Press Release Announcing the Appointment of Clinical Advisory Board Members	Feb. 08	AQ
Palisade Bio, Inc. Announces Advisory Board Appointments	Feb. 08	CI
Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders	Feb. 08	AQ
Palisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Million	Jan. 30	AQ
Sector Update: Health Care Stocks Stronger Late Afternoon	Jan. 29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Neuralstem, Inc. Nasdaq

Equities

US64127R3021

Summary

Filters